MKGAF
Price
$130.59
Change
+$1.08 (+0.83%)
Updated
Nov 12 closing price
Capitalization
56.6B
Intraday BUY SELL Signals
MKKGY
Price
$26.90
Change
+$0.72 (+2.75%)
Updated
Nov 12 closing price
Capitalization
56.6B
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

MKGAF vs MKKGY

Header iconMKGAF vs MKKGY Comparison
Open Charts MKGAF vs MKKGYBanner chart's image
Merck KGaA
Price$130.59
Change+$1.08 (+0.83%)
Volume$148
Capitalization56.6B
Merck KGaA
Price$26.90
Change+$0.72 (+2.75%)
Volume$92.05K
Capitalization56.6B
MKGAF vs MKKGY Comparison Chart in %
MKGAF
Daily Signal:
Gain/Loss:
MKKGY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MKGAF vs. MKKGY commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKGAF is a Hold and MKKGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (MKGAF: $130.59 vs. MKKGY: $26.90)
Brand notoriety: MKGAF and MKKGY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MKGAF: 24% vs. MKKGY: 63%
Market capitalization -- MKGAF: $58.31B vs. MKKGY: $58.31B
MKGAF [@Pharmaceuticals: Generic] is valued at $58.31B. MKKGY’s [@Pharmaceuticals: Generic] market capitalization is $58.31B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKGAF’s FA Score shows that 1 FA rating(s) are green whileMKKGY’s FA Score has 1 green FA rating(s).

  • MKGAF’s FA Score: 1 green, 4 red.
  • MKKGY’s FA Score: 1 green, 4 red.
According to our system of comparison, MKKGY is a better buy in the long-term than MKGAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKGAF’s TA Score shows that 3 TA indicator(s) are bullish while MKKGY’s TA Score has 6 bullish TA indicator(s).

  • MKGAF’s TA Score: 3 bullish, 6 bearish.
  • MKKGY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MKKGY is a better buy in the short-term than MKGAF.

Price Growth

MKGAF (@Pharmaceuticals: Generic) experienced а -0.89% price change this week, while MKKGY (@Pharmaceuticals: Generic) price change was +5.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.08%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +32.16%.

Reported Earning Dates

MKKGY is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKGAF($56.6B) and MKKGY($56.6B) have the same market capitalization . MKKGY (17.66) and MKGAF (17.15) have similar P/E ratio . MKKGY YTD gains are higher at: -4.363 vs. MKGAF (-13.836). MKGAF (5.87B) and MKKGY (5.87B) have comparable annual earnings (EBITDA) . MKGAF (1.57B) and MKKGY (1.57B) have equal amount of cash in the bank . MKGAF (9.4B) and MKKGY (9.4B) have identical debt. MKGAF (21.2B) and MKKGY (21.2B) have equivalent revenues.
MKGAFMKKGYMKGAF / MKKGY
Capitalization56.6B56.6B100%
EBITDA5.87B5.87B100%
Gain YTD-13.836-4.363317%
P/E Ratio17.1517.6697%
Revenue21.2B21.2B100%
Total Cash1.57B1.57B100%
Total Debt9.4B9.4B100%
FUNDAMENTALS RATINGS
MKGAF vs MKKGY: Fundamental Ratings
MKGAF
MKKGY
OUTLOOK RATING
1..100
1970
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6969
PRICE GROWTH RATING
1..100
7360
P/E GROWTH RATING
1..100
8180
SEASONALITY SCORE
1..100
233

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKGAF's Valuation (23) in the null industry is in the same range as MKKGY (23). This means that MKGAF’s stock grew similarly to MKKGY’s over the last 12 months.

MKGAF's Profit vs Risk Rating (100) in the null industry is in the same range as MKKGY (100). This means that MKGAF’s stock grew similarly to MKKGY’s over the last 12 months.

MKGAF's SMR Rating (69) in the null industry is in the same range as MKKGY (69). This means that MKGAF’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's Price Growth Rating (60) in the null industry is in the same range as MKGAF (73). This means that MKKGY’s stock grew similarly to MKGAF’s over the last 12 months.

MKKGY's P/E Growth Rating (80) in the null industry is in the same range as MKGAF (81). This means that MKKGY’s stock grew similarly to MKGAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKGAFMKKGY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
57%
Declines
ODDS (%)
Bearish Trend 10 days ago
64%
Bearish Trend 9 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
MKGAF
Daily Signal:
Gain/Loss:
MKKGY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NOA14.440.27
+1.91%
North American Construction Group Ltd
CHPGU10.290.02
+0.19%
Championsgate Acquisition Corp
RVTY94.13-0.18
-0.19%
Revvity
ANIP87.27-1.27
-1.43%
ANI Pharmaceuticals
AMTD0.89-0.06
-6.30%
AMTD IDEA Group

MKGAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
+0.83%
MKKGY - MKGAF
49%
Loosely correlated
+2.75%
AQST - MKGAF
19%
Poorly correlated
-1.93%
INDV - MKGAF
17%
Poorly correlated
-3.12%
EVO - MKGAF
17%
Poorly correlated
+5.72%
EBS - MKGAF
16%
Poorly correlated
-0.64%
More

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+2.75%
MKGAF - MKKGY
49%
Loosely correlated
+0.83%
AMPH - MKKGY
25%
Poorly correlated
+2.47%
ZTS - MKKGY
25%
Poorly correlated
+0.94%
SUPN - MKKGY
25%
Poorly correlated
-3.23%
INDV - MKKGY
24%
Poorly correlated
-3.12%
More